Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Go back to Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights
(NASDAQ: NVCT) Delayed: 22.04 +0.17 (0.78%)
Previous Close $21.87    52 Week High
Open $22.31    52 Week Low
Day High $22.31    P/E N/A 
Day Low $21.94    EPS
Volume 6,127